“FACTORS DETERMINING THE CLINICAL SIGNIFICANCE OF DEPIPTIDYL PEPTIDASE 4 INHIBITORS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS” (2022) World Bulletin of Public Health, 8, pp. 67–72. Available at: https://www.scholarexpress.net/index.php/wbph/article/view/651 (Accessed: 18 April 2026).